Anixa Biosciences Stock Filter Stocks by Fundamentals
| ANIX Stock | USD 3.30 0.01 0.30% |
Anixa Biosciences fundamentals help investors to digest information that contributes to Anixa Biosciences' financial success or failures. It also enables traders to predict the movement of Anixa Stock. The fundamental analysis module provides a way to measure Anixa Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anixa Biosciences stock.
Anixa | Shares Owned by Institutions |
Anixa Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Anixa Biosciences from analyzing Anixa Biosciences' financial statements. These drivers represent accounts that assess Anixa Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Anixa Biosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 71.4M | 76.6M | 45.8M | 145.5M | 167.3M | 140.1M | |
| Enterprise Value | 68.3M | 73.1M | 39.4M | 116.6M | 134.1M | 134.2M |
Anixa Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Anixa Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Anixa Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Anixa Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Anixa Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Anixa Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Anixa Biosciences' value.| Shares | Bank Of New York Mellon Corp | 2024-06-30 | 73 K | Northern Trust Corp | 2024-09-30 | 71 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 69 K | Corecap Advisors, Llc | 2024-06-30 | 46.9 K | Tyler-stone Wealth Management | 2024-09-30 | 42 K | Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 41.1 K | International Assets Investment Management, Llc | 2024-09-30 | 37.8 K | Ci Private Wealth Llc | 2024-06-30 | 37.4 K | Gemmer Asset Management Llc | 2024-06-30 | 35 K | Vanguard Group Inc | 2024-09-30 | 1.4 M | Davidson D A & Co | 2024-06-30 | 736.4 K |
Anixa Fundamentals
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 86.01 M | ||||
| Shares Outstanding | 32.18 M | ||||
| Shares Owned By Insiders | 5.05 % | ||||
| Shares Owned By Institutions | 17.40 % | ||||
| Number Of Shares Shorted | 411.56 K | ||||
| Price To Earning | (51.83) X | ||||
| Price To Book | 4.89 X | ||||
| Price To Sales | 481.54 X | ||||
| Revenue | 210 K | ||||
| Gross Profit | 127.5 K | ||||
| EBITDA | (10.96 M) | ||||
| Net Income | (9.93 M) | ||||
| Cash And Equivalents | 31.66 M | ||||
| Cash Per Share | 1.03 X | ||||
| Total Debt | 175 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 22.01 X | ||||
| Book Value Per Share | 0.68 X | ||||
| Cash Flow From Operations | (6.21 M) | ||||
| Short Ratio | 3.58 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Target Price | 8.5 | ||||
| Beta | 0.85 | ||||
| Market Capitalization | 106.19 M | ||||
| Total Asset | 25.52 M | ||||
| Retained Earnings | (228.2 M) | ||||
| Working Capital | 23.33 M | ||||
| Current Asset | 10.38 M | ||||
| Current Liabilities | 1.36 M | ||||
| Net Asset | 25.52 M |
About Anixa Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anixa Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anixa Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anixa Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Anixa Stock Analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.